Hologic (HOLX) FY Conference June 04, 2025 05:00 PM ET Speaker0 Thanks for joining us here as we begin to wrap up the second day of the William Blair Growth Stock Conference. If you haven't met me, I'm Andrew Brackman. I'm the diagnostics analyst here at William Blair that covers Hologic. Today, we're pleased to have the team, including CFO, Carleen Oberton and from Investor Relations, Peter Sattler. I am required to tell you that for a full list of research disclosures, please visit williamblair.com, and t ...

Key Takeaways HOLX's Breast Health segment fell 6.2% in Q2, continuing a decline led by weaker capital equipment sales. Despite softness, Hologic's service revenues rose 12%, driven by a large global gantry install base. HOLX eyes a growth rebound in Q4 and plans a 2026 launch of its FDA-cleared Envision mammography platform.Women’s health medical device maker, Hologic (HOLX) , is struggling with continued softness in its core Breast Health segment. Sales fell 6.2% in the fiscal 2025 second quarter due to ...